BSX vs. BDX

Last updated Jun 3, 2026

BSX (Boston Scientific Corporation) and BDX (Becton, Dickinson and Company) are both stocks. Both are in the Healthcare sector — BSX in Medical Devices, BDX in Medical Instruments & Supplies. Over the past 10 years, BSX returned 7.66%/yr vs 2.63%/yr for BDX. At a 0.34 correlation, their price movements are largely independent.

Performance

BSX vs. BDX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Boston Scientific Corporation (BSX) and Becton, Dickinson and Company (BDX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BSX achieves a -49.99% return, which is significantly lower than BDX's -4.73% return. Over the past 10 years, BSX has outperformed BDX with an annualized return of 7.66%, while BDX has yielded a comparatively lower 2.63% annualized return.

BSX

• 1D: -0.63%
• 1M: -15.61%
• YTD: -49.99%
• 6M: -51.85%
• 1Y: -54.23%
• 3Y*: -2.74%
• 5Y*: 2.89%
• 10Y*: 7.66%

BDX

• 1D: -0.62%
• 1M: -3.27%
• YTD: -4.73%
• 6M: -2.40%
• 1Y: 11.00%
• 3Y*: -8.29%
• 5Y*: -3.19%
• 10Y*: 2.63%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BSX vs. BDX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
BSX Boston Scientific Corporation	-49.99%	6.75%	54.51%	24.94%	8.92%	18.16%	-20.50%	27.96%	42.56%	14.61%
BDX Becton, Dickinson and Company	-4.73%	-12.61%	-5.38%	-2.67%	5.08%	1.88%	-6.75%	22.20%	6.61%	31.24%

Correlation

The correlation between BSX and BDX is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.28
Correlation (3Y) Calculated over the trailing 3-year period	0.33
Correlation (5Y) Calculated over the trailing 5-year period	0.42
Correlation (10Y) Calculated over the trailing 10-year period	0.47
Correlation (All Time) Calculated using the full available price history since May 20, 1992	0.34

The correlation between BSX and BDX shifts across timeframes, from 0.28 (1 year) to 0.47 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap BSX : $71.28B BDX : $40.53B
EPS BSX : $2.38 BDX : $3.99
PE Ratio BSX : 20.06 BDX : 36.22
PS Ratio BSX : 3.46 BDX : 1.93
PB Ratio BSX : 2.76 BDX : 1.68
Total Revenue (TTM) BSX : $20.62B BDX : $21.37B
Gross Profit (TTM) BSX : $14.52B BDX : $9.93B
EBITDA (TTM) BSX : $4.76B BDX : $4.16B

Return for Risk

BSX vs. BDX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BSX

BSX Risk / Return Rank: 1
BSX Sharpe Ratio Rank: 0
BSX Sortino Ratio Rank: 1
BSX Omega Ratio Rank: 1
BSX Calmar Ratio Rank: 2
BSX Martin Ratio Rank: 0

BDX

BDX Risk / Return Rank: 51
BDX Sharpe Ratio Rank: 55
BDX Sortino Ratio Rank: 51
BDX Omega Ratio Rank: 48
BDX Calmar Ratio Rank: 49
BDX Martin Ratio Rank: 51

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BSX vs. BDX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Boston Scientific Corporation (BSX) and Becton, Dickinson and Company (BDX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BSX	BDX	Difference
Sharpe ratio Return per unit of total volatility	-1.57	0.44	-2.01
Sortino ratio Return per unit of downside risk	-2.40	0.94	-3.34
Omega ratio Gain probability vs. loss probability	0.65	1.10	-0.45
Calmar ratio Return relative to maximum drawdown	-0.98	0.39	-1.37
Martin ratio Return relative to average drawdown	-2.25	0.97	-3.22
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BSX vs. BDX - Sharpe Ratio Comparison

The current BSX Sharpe Ratio is -1.57, which is lower than the BDX Sharpe Ratio of 0.44. The chart below compares the historical Sharpe Ratios of BSX and BDX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	BSX	BDX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-1.57	0.44	-2.01
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.11	-0.14	+0.25
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.28	0.11	+0.17
Sharpe Ratio (All Time) Calculated using the full available price history	0.19	0.42	-0.22

Drawdowns

BSX vs. BDX - Drawdown Comparison

The maximum BSX drawdown since its inception was -89.15%, which is greater than BDX's maximum drawdown of -51.17%. Use the drawdown chart below to compare losses from any high point for BSX and BDX.

Drawdown Indicators

	BSX	BDX	Difference
Max Drawdown Largest peak-to-trough decline	-89.15%	-51.17%	-37.98%
Max Drawdown (1Y) Largest decline over 1 year	-55.91%	-22.73%	-33.18%
Max Drawdown (3Y) Largest decline over 3 years	-55.91%	-40.06%	-15.85%
Max Drawdown (5Y) Largest decline over 5 years	-55.91%	-40.06%	-15.85%
Max Drawdown (10Y) Largest decline over 10 years	-55.91%	-40.06%	-15.85%
Current Drawdown Current decline from peak	-55.91%	-31.75%	-24.16%
Average Drawdown Average peak-to-trough decline	-38.75%	-11.57%	-27.18%
Ulcer Index Depth and duration of drawdowns from previous peaks	24.31%	9.21%	+15.10%

Volatility

BSX vs. BDX - Volatility Comparison

Boston Scientific Corporation (BSX) has a higher volatility of 16.24% compared to Becton, Dickinson and Company (BDX) at 9.90%. This indicates that BSX's price experiences larger fluctuations and is considered to be riskier than BDX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BSX	BDX	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.24%	9.90%	+6.34%
Volatility (6M) Calculated over the trailing 6-month period	32.81%	18.18%	+14.63%
Volatility (1Y) Calculated over the trailing 1-year period	34.64%	24.91%	+9.73%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	25.66%	23.25%	+2.41%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	27.29%	23.56%	+3.73%

Dividends

BSX vs. BDX - Dividend Comparison

BSX has not paid dividends to shareholders, while BDX's dividend yield for the trailing twelve months is around 2.43%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BDX Becton, Dickinson and Company	2.43%	2.15%	1.71%	1.51%	1.38%	1.34%	1.28%	1.14%	1.34%	1.37%	1.64%	1.60%
BSX Boston Scientific Corporation	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

BSX vs. BDX - Profitability Comparison

The chart below illustrates the profitability comparison between Boston Scientific Corporation and Becton, Dickinson and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

BSX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a gross profit of 3.61B and revenue of 5.20B. Therefore, the gross margin over that period was 69.4%.

BDX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Becton, Dickinson and Company reported a gross profit of 2.15B and revenue of 4.71B. Therefore, the gross margin over that period was 45.7%.

BSX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported an operating income of 1.07B and revenue of 5.20B, resulting in an operating margin of 20.6%.

BDX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Becton, Dickinson and Company reported an operating income of 94.00M and revenue of 4.71B, resulting in an operating margin of 2.0%.

BSX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a net income of 1.34B and revenue of 5.20B, resulting in a net margin of 25.7%.

BDX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Becton, Dickinson and Company reported a net income of -311.00M and revenue of 4.71B, resulting in a net margin of -6.6%.

Frequently Asked Questions

Can I hold both BSX and BDX in my portfolio?

BSX and BDX have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BSX or BDX?

BSX has higher volatility (16.24%) compared to BDX (9.90%). In terms of maximum drawdown, BSX dropped -89.15% vs BDX's -51.17%.

Which has better risk-adjusted returns?

BDX currently has the higher Sharpe Ratio (0.44 vs -1.57), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.